3 hours Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Consensus Recommendation of “Hold” by Analysts MarketBeat
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Free Report) has earned an average rating of “Hold” from the ten research firms that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, six have i…